GOLCADOMIDE: 30 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
30
Total FAERS Reports
1 (3.3%)
Deaths Reported
22
Hospitalizations
30
As Primary/Secondary Suspect
3
Life-Threatening
First Report: 20220806 · Latest Report: 20250523
What Are the Most Common GOLCADOMIDE Side Effects?
#1 Most Reported
Diffuse large b-cell lymphoma refractory
6 reports (20.0%)
#2 Most Reported
Diffuse large b-cell lymphoma recurrent
6 reports (20.0%)
#3 Most Reported
Febrile bone marrow aplasia
5 reports (16.7%)
All GOLCADOMIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Diffuse large b-cell lymphoma recurrent | 6 | 20.0% | 0 | 0 |
| Diffuse large b-cell lymphoma refractory | 6 | 20.0% | 0 | 0 |
| Febrile bone marrow aplasia | 5 | 16.7% | 0 | 5 |
Who Reports GOLCADOMIDE Side Effects? Age & Gender Data
Gender: 73.9% female, 26.1% male. Average age: 64.8 years. Most reports from: FR. View detailed demographics →
Is GOLCADOMIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 1 | 1 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 18 | 0 | 18 |
| 2025 | 1 | 0 | 1 |
What Is GOLCADOMIDE Used For?
| Indication | Reports |
|---|---|
| Diffuse large b-cell lymphoma | 19 |
| High-grade b-cell lymphoma | 8 |
Official FDA Label for GOLCADOMIDE
Official prescribing information from the FDA-approved drug label.